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Synergistic effect of dexamethasone and isoproterenol on angiotensino-
gen in immortalized rat proximal tubular cells. To investigate whether the
expression of angiotensinogen (ANG) in rat kidney proximal tubules is
stimulated by dexamethasone and isoproterenol, immortalized rat proxi-
mal tubular cells (IRPTC) were cultured in a monolayer. Immunoreactive
rat ANG (IR-rANG) in the culture medium was measured by a specific
radioimmunoassay (RIA) for rANG. This RIA was developed by employ-
ing rabbit antiserum against the purified recombinant rat ANG (rANG).
The purified rANG from plasma and the iodinated rANG were used as the
hormone standard and tracer, respectively. The RIA is specific for rat
ANG and it has no cross-reactivity with other pituitary hormone prepa-
rations or other rat plasma proteins. The sensitivity of detection of the
RIA is approximately 2 ng of rANG. The levels of IR-rANG in the culture
media of IRPTC ranged from 2 to 5 ng/ml/24 hr/106 cells. The addition of
dexamethasone (10213 to 1025 M) stimulated the expression and secretion
of rANG from IRPTC in a dose-dependent manner, whereas the addition
of isoproterenol alone had no effect. However, a combination of both
dexamethasone and isoproterenol synergistically stimulated the expres-
sion and secretion of rANG by IRPTC. The synergistic effect of dexa-
methasone and isoproterenol was blocked by the presence of RU 486 (a
glucocorticoid receptor antagonist) or propranolol (b-adrenoceptor block-
er). These studies suggest that the addition of dexamethasone and
isoproterenol acts synergistically to stimulate the expression and secretion
of ANG protein in rat proximal tubules in vivo.
Angiotensin II (Ang II), an octapeptide derived from the
precursor protein angiotensinogen (ANG), exerts a dose-depen-
dent biphasic effect on proximal tubular sodium reabsorption
[1–3] and induces growth of the maturing kidney [4]. This study
indicates that Ang II may play an important role in the control of
electrolyte reabsorption in the kidney and in maintaining renal
glomerular growth.
Physiological studies have shown that the levels of Ang I and
Ang II in the luminal fluid in rat proximal tubules are as high as
1029 M, whereas the levels of plasma Ang I or Ang II are less than
10212 M [5, 6], suggesting that high levels of Ang I and Ang II in
the renal tubular fluid exceed those that can be accounted for
from the circulation (glomerular filtrate). Furthermore, ANG
mRNA has been localized in rat proximal tubules by the tech-
niques of in situ hybridization [7] and polymerase chain reaction
[8]. Recent studies have also shown that the mRNAs for the
components of RAS, including ANG, renin, angiotensin-convert-
ing enzyme and angiotensin-II receptor (AT1-receptor) are ex-
pressed in murine (mouse and rat) immortalized proximal tubular
cell lines [9–11]. We [12, 13] have also demonstrated that the
ANG mRNA is expressed in opossum kidney (OK) proximal
tubular cells. All these studies provide evidence that the intrarenal
Ang II is probably derived from the ANG that is synthesized in
renal proximal tubular cells. To our knowledge, until now there
has been no report on the expression and secretion of the ANG
protein from the proximal tubular cells. Hence, experimental
evidence to demonstrate that the ANG protein is expressed and
secreted from the proximal tubular cells is definitely warranted.
The objective of the present studies was to develop a specific
radioimmunoassay (RIA) for rANG by employing rabbit anti-
serum against the purified recombinant rat ANG (rANG). This
RIA-rANG was used to quantify the level of ANG protein
expressed and secreted from the immortalized rat proximal
tubular cells (IRPTC) in vitro. We also investigated whether the
expression of the ANG could be modulated in the presence of
dexamethasone and isoproterenol (IRPTC) in vitro.
Our studies showed that the total amount of IR-rANG in the
cell extract of IRPTC was less than 5% of that detected in the
medium. The addition of dexamethasone alone stimulated the
expression and secretion of ANG in IRPTC in a dose-dependent
manner, whereas isoproterenol alone had no effect. Furthermore,
a combination of both dexamethasone and isoproterenol syner-
gistically stimulated the expression of ANG in IRPTC. This
stimulatory effect of dexamethasone and isoproterenol could be
blocked by the presence of RU 486 (an antagonist of glucocorti-
coid) or propranolol (a non-selective b-adrenoceptor blocker).
Our present results confirm the recent report of Loghman-Adham
[11] who showed that the addition of dexamethasone (1026 M)
stimulated the expression of mouse ANG as measured by indirect
radioimmunoassay in immortalized murine proximal tubular cells.
Key words: dexamethasone, isoproterenol, angiotensinogen, immortalized
PT cells, proximal tubule cells.
Received for publication June 23, 1997
and in revised form September 8, 1997
Accepted for publication September 10, 1997
© 1998 by the International Society of Nephrology
Kidney International, Vol. 53 (1998), pp. 287–295
287
METHODS
Materials
All of the hormone preparations listed below, with the excep-
tion of human ANG (hANG) and rat albumin, were kindly
supplied by the NIAMDD of the National Institutes of Health
(NIAMDD-hGH-I-1 AFP-4793B; NIH, Bethesda, MD, USA), rat
growth hormone (rGH; NIADDK-rGH-RP-2, 0.6 IU/mg), rat
thyroid stimulatory hormone (rTSH; NIADDK-rTSH-RP-2,
AFP-5153B), rat luteinizing hormone (rLH; NIADDK-rLH-
RP-2, AFP-566C), rat prolactin (rPRL; NIADDK-rPRL-RP-3,
AFP-4459B). Human angiotensinogen and rat albumin were
purchased from Calbiochem-Novabiochem Corporation (La Jolla,
CA, USA) and Sigma Chemicals (St. Louis, MO, USA), respec-
tively.
R(-)-isoproterenol(1)bitartrate salt (a b-adrenoceptor ago-
nist), S(-)-propranolol hydrochloride (an inhibitor of b1 and b2
adrenoceptors) were purchased from Research Biochemicals Inc.
(RBI, Natick, MA, USA). Dexamethasone was purchased from
Sigma Chemicals. RU 486 (an antagonist of glucocorticoid) was a
gift provided by Dr. Alain Be´langer (Laval University, Quebec,
Canada).
Na125I was purchased from Dupont, New England Nuclear
(NEN, Boston, MA, USA).
Purification of recombinant rat angiotensinogen from bacteria
and rat plasma
The plasmid containing the full-length of rat ANG cDNA,
pGEM (rANG cDNA) was obtained from Dr. Joel F. Habener
(MGH, Boston, MA, USA). The rat ANG cDNA was inserted
into a bacterial expression vector, pMalc (New England Biolabs,
Beverly, MA, USA) at the EcoRI polylinker site and then
transformed the E. coli TB-1 cells (New England Biolabs). The
expression of the fusion protein [Maltose-binding protein (MBP)
fused with rat ANG (MBP-rANG)] in TB-1 cells was induced by
addition of 2.5 mM isopropylthiogalactoside (IPTG) into the
culture-medium and incubated for four hours. The bacteria were
then harvested and the MBP-rANG fusion proteins were purified
from the bacterial extracts by amylose resin affinity column
chromatography according to the protocol supplied by the man-
ufacturer (New England Biolabs). The purified MBP-rANG fu-
sion proteins were used to immunize New Zealand white rabbits
(Charles River Inc., St. Constant, Quebec, Canada) according to
the procedures we described previously for ovine placental lacto-
gen [14].
The rabbit polyclonal antibodies (IgG) against the MBP-rANG
fusion protein were purified from the rabbit antiserum by protein
G affinity chromatography according to the protocol supplied by
Pharmacia Inc. The purified IgGs were coupled to CN-activated
Sepharose 4B and then used to set up the IgG-affinity column
(Pharmacia Inc.) for purification of rANG from rat plasma.
Rat plasma ANG was purified by a three step method by
passing sequentially through the IgG-affinity column chromatog-
raphy, a Blue-Sepharose column (purchased from Pharmacia
Inc.) and finally, another IgG-affinity column.
Characterization of MBP-rANG fusion protein and purified rat
plasma angiotensinogen
The purified MBP-rANG fusion protein and the purified rat
plasma ANG preparations were analyzed by a linear gradient of 6
to 15% polyacrylamide gel electrophoresis containing sodium
dodecyl sulfate (PAGE-SDS) [15]. The protein standard markers
(Rainbow protein markers) were purchased from Amersham
Canada Ltd. (Oakville, Ontario, Canada).
Western blot analysis was performed to analyze the purified rat
plasma ANG, rat plasma proteins and the concentrated culture
media by employing the rabbit polyclonal antibodies against the
MBP-rANG fusion protein, anti-rabbit horseraddish peroxidase
(HRP; Bio-Rad Laboratories, Richmond, CA, USA) conjugates
and the avidin-HRP conjugates according to the protocol of the
supplier (Bio-Rad).
Radioimmunoassay for rat angiotensinogen
The radioimmunoassay (RIA) procedure was performed ac-
cording to the procedures we described previously for ovine
placental lactogen (oPL) by employing a double-antibody precip-
itation [14]. The purified rat plasma ANG was used for both
iodination and as a hormone standard. The limit of sensitivity of
the assay was 2 ng/ml. The inter- and intra-assay coefficients of
variation were 9% (N 5 10) and 14% (N 5 10), respectively.
Cell culture
Immortalized rat proximal tubular cells (IRPTC; #93-p-2-1)
were obtained by the transfection of rat proximal tubular cells
with the origin-defective SV 40, as previously described [10]. The
characteristics of the IRPTC have been reported previously [10].
Briefly, these cells express the mRNA and protein of ANG, renin,
angiotensin-converting enzyme and angiotensin-II receptor [10].
The rat hepatoma (H-4-II-E, CRL-1548) cells were obtained
from the American Tissue Culture Collection (ATCC, Rockville,
MD, USA). This cell line expresses the ANG mRNA and ANG
and has been used extensively by various investigators [16, 17].
The IRPTC and H-4-II-E cells were grown in 100 3 20 mm
plastic Petri dishes (Gibco, Burlington, Ontario, Canada) in
Dulbecco’s modified Eagle medium (DMEM; pH 7.45), supple-
mented with 10% fetal bovine serum (FBS), 100 U/ml of pencillin
and 100 mg/ml of streptomycin. The cells were grown in a
humidified atmosphere in 95% air—5% CO2 at 37°C. For subcul-
turing, cells were trypsinized (0.05% trypsin and EDTA) and
plated at 2.5 3 104 cells/cm2 in 100 3 20 mm Petri dishes.
Basal expression and secretion of immunoreactive rat
angiotensinogen in immortalized rat proximal tubular cells
The IRPTC were plated at a density of 5 3 106 cells per 100 3
20 mm plastic Petri dish (Gibco) in DMEM, pH 7.45, supple-
mented with 10% FBS and incubated until 90% confluent. Then,
the cells were incubated for 24 hours in medium containing 1%
depleted FBS (dFBS). At the end of the incubation period, media
and cells were harvested and kept at 220° until the assay for
IR-rANG. The cells were extracted with 0.1 M NH4 HCO3 after
sonication. After gentle agitation overnight at 4°C, cell extracts
were centrifuged at 15,000 3 g for 10 minutes at 4°C to remove
the precipitate. The protein content was measured according to
the protocol of the Bio-Rad protein kit. The number of cells were
counted with a hemocytometer.
The total amount of IR-rANG present was corrected by the
volume of medium and cellular extract and expressed as total
nanograms of IR-rANG.
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To analyze the molecular species of IR-rANG, the media were
concentrated by Centricon-10 (Amicon Inc., Beverly, MA, USA)
to less than 5% of the original volume before Western blotting.
The cellular extracts were analyzed by Western blotting without
concentration by Centricon-10.
The depleted fetal bovine serum (dFBS) was prepared by
incubation with 1% activated charcoal and 1% AG 1 3 8 ion
exchange resin (Bio-Rad) for 16 hours or more at room temper-
ature as described by Samuels, Stanley and Shapiro [18]. This
procedure removed endogenous steroid and thyroid hormones
from the FBS as demonstrated by Samuels et al [18].
Effect of dexamethasone or isoproterenol on the expression and
secretion of angiotensinogen by immortalized rat proximal
tubule cells
The IRPTC were plated at a density of 1 to 2 3 106 cells/well
in six-well plates and incubated overnight in DMEM containing
1% depleted FBS. Then, cell growth was arrested by incubation in
serum-free medium for 24 hours. Subsequently, various concen-
trations of dexamethasone (10213 to 1025 M) or isoproterenol
(10215 to 1027 M) were added to the culture medium containing
1% dFBS. At the end of the incubation period, media were
collected and kept at 220°C until assay for IR-rANG.
Synergistic effect of isoproterenol and dexamethasone on the
expression and secretion of angiotensinogen
The IRPTC were plated at a density of 1 to 2 3 106 cells/well
in six-well plates and incubated overnight in DMEM containing
1% dFBS. Then cell growth was arrested by incubation in
serum-free medium for 24 hours. Subsequently, various concen-
trations of isoproterenol (10215 to 1027 M) were added to the
culture medium containing 1% dFBS and incubated for 24 hours
in the absence or presence of 1026 M dexamethasone.
Inhibitory effect of RU 486 or propranolol on the expression
and secretion of angiotensinogen in immortalized rat proximal
tubule cells in the presence of dexamethasone and
isoproterenol
To investigate whether RU 486 or propranolol could block the
effect of dexamethasone and isoproterenol on the expression of
ANG in IRPTC, RU 486 (1025 M) or propranolol (1025 M) were
co-cultured with dexamethasone (1026 M) and isoproterenol
(1027 M) for 24 hours. At the end of the incubation period, the
media were collected and kept at 220°C until assay.
Statistical analysis
The experiments were performed at least three times in tripli-
cate. The data were analyzed with the Student’s t-test or ANOVA
analysis. A probability level of P # 0.05 was regarded as signifi-
cant.
RESULTS
Purification and characterization of recombinant rat
angiotensinogen from the bacteria and rat plasma
Figure 1 shows the analysis of the MBP-rANG fusion proteins
by 6 to 15% polyacrylamide gel electrophoresis containing sodium
dodecyl sulfate (PAGE-SDS). Three major bands with apparent
molecular weights of 46, 69 and 97 kDa for MBP-rANG were
observed. The 46 kDa molecular species was the induced maltose-
binding protein as suggested by the supplier (New England
Biolabs). The 97 kDa molecular species was the molecular weight
of deglycosylated rANG (that is, 51 kDa) fused with the MBP (46
kDa), whereas the 69 kDa molecular species was probably the
partially degraded MBP-rANG fusion proteins. The mixture of
these three major species was used to immunize rabbits to raise
polyclonal antibodies.
Rat plasma ANG was purified by three consecutive chromato-
graphic steps including an IgG-affinity column, a Blue-Sepharose
column and a second IgG-affinity column. It is evident that at
least two major molecular species with apparent molecular
weights of approximately 56 and 62 kDa were observed for the
purified rat plasma ANG preparation (lane 3, Fig. 2A). Their
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Fig. 1. Linear gradient 6 to 15% polyacrylamide gel electrophoresis
containing sodium dodecyl sulfate (PAGE-SDS) analysis of the maltose-
binding protein—rat ANG (MBP-rANG) fusion protein from the bacte-
rial culture. Lane 1 (Amersham’s Rainbow markers), lane 2 [crude
bacterial extract without induction by isopropylthiogalactoside (IPTG),
150 mg], lane 3 (crude bacterial extract with induction by IPTG, 150 mg),
lane 4 (crude bacterial extract after 10 to 50% ammonium sulfate
precipitation, 150 mg), lane 5 (purified MBP-rANG after amylose resin
column chromatography, 150 mg) and lane 6 (purified MBP-rANG after
the amylose resin column chromatography, 15 mg).
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molecular weights were consistent with those reported in the
literature.
Western blot analysis (Fig. 2B) shows that the antiserum against
the MBP-rANG fusion protein interacted with the purified rANG
from rat plasma and the ANG in the rat plasma (lanes 3, 4 and 5),
but did not interact with the purified bovine serum albumin (lane
1), human ANG (lane 2) and other proteins in the rat plasma.
Again, both forms of rat ANG (that is, 56 and 62 kDa) interacted
well with the antiserum against the MBP-rANG fusion protein.
These studies demonstrate that the antiserum against MBP-
rANG is specific for rat ANG and has no cross-reactivity with
bovine serum albumin or other rat plasma proteins, suggesting
that the antiserum is suitable to develop the radioimmunoassay
for rANG.
Radioimmunoassay for rat angiotensinogen
Figure 3 shows the typical standard curve for the radioimmu-
noassay of rat ANG (RIA-rANG) by employing the rabbit
antiserum against the MBP-rANG fusion proteins. The purified
rat plasma ANG and the iodinated rANG were used as hormone
standard and tracer, respectively. The lower limit of sensitivity of
the RIA was approximately 2 ng of rANG. It has no cross-
reactivity with either rat albumin or rat pituitary hormone prep-
arations (rGH, rTSH, rLH and rPRL) or plasma samples of the
dog, cat, hamster and human. Serial dilutions of rat and mouse
plasma samples, however, displayed a parallelism with the purified
rat ANG standard. Similarly, serial dilutions of the culture media
from IRPTC and the rat hepatoma (H-4-II-E) cells displayed a
parallelism with the rat ANG standard (Fig. 4). On the other
hand, minimal cross-reactivity (or non-parallelism) was observed
for the culture medium containing 1% dFBS. These studies
demonstrate that the RIA is specific for rANG and is suitable to
quantify the level of IR-rANG in the rat or mouse plasma and in
the culture medium of IRPTC and H-4-II-E cells.
Basal expression of the immunoreactive rat angiotensinogen in
immortalized rat proximal tubule cells
Table 1 compares the levels of the IR-rANG in the media and
cell extracts of IRPTC that were incubated for 24 hours in the
medium containing 1% dFBS. It is obvious that the total amount
of IR-rANG in the cell extract was less than 5% (range 2 to 3%)
of that detected in the medium. These studies indicate that the
rANG expressed in the IRPTC is not stored within these cells but
is secreted constitutively by these cells. Hence, these data indicate
that the level of IR-rANG measured in the culture medium is a
good indication of the level of ANG expressed in these cells.
Figure 5 shows the Western blot analysis of the IR-rANG in
IRPTC culture medium and cell extract by employing antibodies
against the rat ANG-MBP fusion protein. The IRPTC culture
medium was concentrated by Centricon-10. Two major molecular
species of rANG were apparent in the IRPTC cell culture
medium, one major band with a molecular weight of 62 kDa, and
one minor band with a molecular weight of 56 kDa. On the other
hand, the 56 kDa protein was the major species in IRPTC cell
extract. These studies demonstrate that the 62 kDa rANG is the
major secretory form of the rANG from the IRPTC.
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Fig. 2. Linear gradient 6 to 15% PAGE-SDS
analysis (A) and Western blot analysis (B) of
the purified rat plasma angiotensinogen
(ANG). (A) Six to 15% PAGE-SDS analysis,
lane 1 (rat albumin, 10 mg)), lane 2 (rat plasma,
10 mg) and lane 3 (purified rat plasma ANG
after two passes through the IgG-affinity
column and one pass through the Blue-
Sepharose column, 10 mg). (B) Western blot
analysis, lane 1 (bovine serum albumin, 10 mg),
lane 2 (human ANG 10 mg), lane 3 (purified
rat plasma ANG, 10 mg), lane 4 (5 ml of rat
plasma) and lane 5 (10 ml of rat plasma). The
apparent molecular weight of Amersham’s
Rainbow markers are indicated on the left of
each panel. The apparent molecular weights of
rat ANG are indicated on the right of each
panel.
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Effect of dexamethasone or isoproterenol on the expression of
angiotensinogen in immortalized rat proximal tubule cells
Figure 6 shows that the addition of dexamethasone (10213 to
1025 M) stimulated the expression of immunoreactive-rANG
(IR-rANG) in IRPTC in a dose-dependent manner. The maximal
and one-half maximal stimulation of the expression of the IR-
rANG were found with 1025 M and 1029 M of dexamethasone,
respectively. The addition of dexamethasone (1025 M) stimulated
the expression of the IR-rANG by 2.5-fold (P # 0.01) in IRPTC.
Similar results were obtained from three independent experi-
ments.
On the other hand, the addition of isoproterenol (10215 to 1027
M) alone had no significant stimulatory effect on the expression of
IR-rANG in IRPTC (Fig. 7). Similar results were observed from
five independent experiments.
These studies demonstrate that the addition of dexamethasone
alone stimulated the expression of IR-rANG in IRPTC whereas
the addition of isoproterenol alone had no effect.
Synergistic effect of dexamethasone and isoproterenol on the
expression of the immunoreactive rat angiotensinogen in
immortalized rat proximal tubule cells
Figure 8 shows that the addition of isoproterenol (10213 to 1027
M) enhanced the stimulatory effect of dexamethasone (1026 M) on
the expression of the IR-rANG in IRPTC. The maximal enhanc-
ing effect of isoproterenol was observed at 1029 to 1027 M. Similar
results were obtained from three other experiments.
Inhibitory effect of RU 486 or propranolol on the expression of
immunoreactive rat angiotensinogen in immortalized rat
proximal tubule cells stimulated by dexamethasone and/or
isoproterenol
Figure 9 shows that the addition of RU 486 (1025 M) completely
blocked the stimulatory effect of dexamethasone (1026 M) on the
expression of IR-rANG in IRPTC. These studies demonstrate
that the effect of dexamethasone on the expression of IR-rANG
in IRPTC is mediated via the glucocorticoid receptor.
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Fig. 3. Radioimmunoassay for rat
angiotensinogen (RIA-rANG) by employing
rabbit polyclonal antibodies against the
Maltose-binding protein-rat angiotensinogen
(MBP-rANG) fusion protein. Iodinated purified
rat ANG and rat ANG were used as tracer and
standard, respectively. Plasma samples from the
rat (F,  and E) and mouse (X) were serially
diluted (that is, dilution in 1:10 to 1:10,000) in
RIA-buffer and assayed. Serial dilutions of rat
and mouse plasma samples displayed a
parallelism with the purified rat ANG standard.
No cross-reactivity was observed with rat
pituitary hormone preparations and plasma
samples from the dog, cat, hamster and human.
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Fig. 4. Cross-reactivity of the culture media in the radioimmunoassay-
rat angiotensinogen (RIA-rANG) culture media, with or without prior
concentration by Centricon-10, were serially diluted in RIA buffer before
assay (E, DMEM 1 1% dFBS; X, IRPTC medium without concentration;
F, IRPTC medium with dexamethasone stimulation; f, IRPTC medium
with 20-fold concentration by Centricen-10; , H-4-II-E medium without
concentration).
Table 1. Comparison of levels of immunoreactive rat angiotensinogen
(IR-rANG) in 10 ml of culture medium and corresponding cell extract
of immortalized rat proximal tubule cells (IRPTC; N 5 3)
Total content IRPTC
Culture medium ng 42.61 6 8.12
Cell extract ng 0.93 6 0.05
Ratio of IR-rANG medium/cell extract 46 5 1
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Figure 10 shows that the addition of propranolol (1025 M)
partially blocked the synergistic effect of dexamethasone and
isoproterenol on the expression of the IR-rANG in IRPTC.
Moreover, the addition of RU 486 completely blocked the
synergistic effect of dexamethasone and isoproterenol. These
studies demonstrate that the synergistic effect of dexamethasone
and isoproterenol on the expression of IR-rANG in IRPTC
requires the presence of both the activated glucocorticoid recep-
tors and the b-adrenoceptors.
DISCUSSION
There are two major advantages for utilizing the bacterial
expression system to isolate recombinant protein for immuniza-
tion. First, the bacterial expression will yield a sufficient amount
of fusion protein for routine immunization and the fusion gene is
easily purified from the bacterial culture. Secondly, the foreign
proteins expressed by the bacteria are usually non-glycosylated.
These non-glycosylated proteins are useful to raise antibodies
against the protein backbone. Indeed, we were able to purify
approximately 300 to 500 mg of MBP-rANG fusion protein from
one liter of bacterial culture. This was sufficient to enable us to
immunize three rabbits at least three times.
The purified MBP-rANG fusion protein preparation consisted
of at least three major bands (that is, 46, 69 and 97 kDa in
apparent molecular weight; Fig. 1). The 97 kDa MBP-rANG
represents the intact rANG fused with MBP (the apparent
molecular weights of non-glycosylated rANG and the induced
MBP protein are 51 kDa and 46 kDa, respectively). No attempts,
however, were made to separate the 97 kDa MBP-rANG fusion
protein more completely from other proteins. We used similar
preparations for immunization of the rabbits.
Our purified rANG from rat plasma displayed at least two
major bands with apparent molecular weights of 56 and 62 kDa as
analyzed by a 6 to 15% linear gradient PAGE-SDS (Fig. 2A). By
Western blot analysis, both molecular species of the purified rat
plasma ANG (56 and 62 kDa) interacted well with the antiserum
against the purified MBP-rANG fusion protein (Fig. 2B). The
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Fig. 5. Western blot analysis of the culture medium and cell extract of
immortalized rat proximal tubule cells (IRPTC). The culture medium was
concentrated 20-fold before Western blotting, and 100 mg or 200 mg of
concentrated medium or cell extract was applied onto each lane. The
apparent molecular weight of Amersham’s Rainbow markers are indicated
on the left, and the apparent molecular weights of rat ANG are indicated
on the right.
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Fig. 6. Effect of dexamethasone on the expression of immunoreactive rat
angiotensinogen (IR-rANG) in immortalized rat proximal tubule cells
(IRPTC). Cells were incubated for up to 24 hours in the presence of
various concentrations of dexamethasone. Media were harvested after 24
hours of incubation and assayed for IR-rANG. The concentration of
IR-rANG in the absence of dexamethasone represents the control (2.25 6
0.49 ng/ml). Each data point represents the mean 6 SD of at least three
determinations (*P # 0.05 and **P # 0.01).
– 10 –15 10 –13 10–11 10– 9 10–7ISOP, M
250
%
 O
f c
on
tro
l
200
150
100
50
0
Fig. 7. Effect of isoproterenol on the expression of immunoreactive rat
angiotensinogen (IR-rANG) in immortalized rat proximal tubule cells
(IRPTC). Cells were incubated for up to 24 hours in the presence of
various concentrations of isoproterenol. Media were then harvested and
assayed for IR-rANG. The concentration of IR-rANG in the absence of
isoproterenol represents the control (that is, 2.88 6 0.17 ng/ml). Each data
point represents the mean 6 SD of at least three determinations.
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presence of two molecular forms of rat plasma ANG is in good
agreement with the studies of Hilgenfeldt and Hackenthal [19],
who isolated two forms of rANG (apparent molecular weights
56.6 and 60 kDa) from the plasma of nephrectomized rats.
A faint IR-rANG band with an apparent molecular weight of 62
kDa was also observed in rat plasma samples (Fig. 2B). We were
surprised that our rabbit antiserum displayed weak cross-reactivity
with the purified human ANG (hANG), despite the fact that there
is at least 60% homology in the amino acid sequence between the
rat and human ANG [20, 21]. At present, we do not have an
explanation for this observation. One possible explanation may be
that the tertiary structure of the rat ANG and human ANG might
play an important role in determining the antigenicity of the
protein. Indeed, more experiments are warranted to clarify this
observation.
Our RIA for rANG displayed no cross-reactivity with rat
albumin, rat pituitary hormones (that is, rGH, rTSH, rLH and
rPRL) and plasma samples from the dog, cat, hamster and human
(Fig. 4), indicating that the RIA is not only specific for ANG but
is also species-specific. On the other hand, serial dilutions of rat
and mouse plasma samples (Fig. 3) and culture media of the
IRPTC and H-4-II-E cells (Fig. 3) displayed a parallelism with the
rANG standard, demonstrating that the RIA is appropriate and
feasible to quantify the levels of IR-rANG in rat and mouse
plasma and in the culture media of IRPTC and H-4-II-E cells.
The amount of total IR-rANG in the cell extract was less than
3% of that detected in the medium (Table 1). These studies
indicate that the ANG expressed in IRPTC is not stored in the
cells, but is constitively secreted by these cells. Hence, the level of
IR-rANG in the medium is a good estimation of the level of
rANG expressed in these cells.
It is interesting that the larger molecular species of rANG (62
kDa) was the predominant form in the medium, whereas the
smaller molecular species of ANG (56 kDa) was the predominant
form in the cell extract (Fig. 5). One possible explanation for the
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Fig. 8. Effect of isoproterenol on the expression of immunoreactive rat
angiotensinogen (IR-rANG) in immortalized rat proximal tubule cells
(IRPTC) in the presence of dexamethasone (1026 M). Cells were incu-
bated for 24 hours in the presence of various concentrations of isoproter-
enol and 1026 M dexamethasone. Media were then harvested and assayed
for IR-rANG. The concentration of IR-rANG in the absence of isopro-
terenol and dexamethasone represents the control (that is, 4.16 6 0.29
ng/ml). Each point represents the mean 6 SD of at least three determi-
nations (*P # 0.05, **P # 0.01 and ***P # 0.005).
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Fig. 9. The inhibitory effect of RU 486 on the expression of immunore-
active rat angiotensinogen (IR-rANG) in immortalized rat proximal
tubule cells (IRPTC) stimulated by dexamethasone. Cells were incubated
for 24 hours in the presence of dexamethasone (1026 M) with or without
the addition of RU 486 (1025 M) (an antagonist of glucocorticoid). Media
were then harvested and assayed for immunoreactive human angio-
tensinogen (IR-hANG). The concentrations of IR-rANG in the absence
of dexamethasone and RU 486 represents the control (that is, 4.72 6 0.28
ng/ml). Each point represents mean 6 SD of at least three determinations
(**P # 0.01).
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Fig. 10. The inhibitory effect of RU 486 or propranolol on the expression
of immunoreactive rat angiotensinogen (IR-rANG) in immortalized rat
proximal tubule cells (IRPTC) stimulated by a combination of dexameth-
asone and isoproterenol. The cells were incubated for 24 hours in the
presence of a combination of both dexamethasone (1026 M) and isopro-
terenol (1027 M) and in the absence or presence of RU 486 (1025 M) or
propranolol (1025 M). Media were then harvested and assayed for
IR-rANG. The concentration of IR-rANG in the absence of dexametha-
sone and isoproterenol represents the control (that is, 6.05 6 0.27 ng/ml).
Each point represents the mean 6 SD of at least three determinations
(**P # 0.01 and ***P # 0.005).
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difference in apparent molecular weight might be due to the level
of glycosylation during the process of maturation and secretion.
Structural studies of the ANG protein have indicated that there
are three potential glycosylation sites in the rANG [22]. Never-
theless, more experiments are warranted to confirm this possibil-
ity.
Our present studies showed that the addition of dexamethasone
stimulated the expression of the ANG in IRPTC in a dose-
dependent manner (1029 to 1025 M; Fig. 6). These concentrations
of dexamethasone are within the physiological concentrations of
plasma cortisol in humans (that is, normal morning plasma level,
13.9 mg/dl or 3.75 3 1027 M) [23]. These studies confirm the
studies of Loghman-Adham et al [11], who reported that the
addition of dexamethasone (1026 M) stimulated the expression of
mouse ANG in immortalized mouse proximal tubular cells. Our
present results also confirm our previous studies in which the
addition of dexamethasone stimulated the expression of ANG-
CAT fusion gene, pOCAT (ANG N-1498/118) containing the
59-flanking regulatory region of the rat ANG gene fused with a
coding sequence of chloramphenicol acetyl transferase (CAT) as
the reporter, in a dose-dependent manner in OK cells [24, 25].
We were surprised to observe that isoproterenol alone had no
significant stimulatory effect on the expression of the rANG in
IRPTC culture (Fig. 7). Our present studies are in disagreement
with our previous studies that the addition of isoproterenol or
8-Bromo-cAMP alone directly stimulated the expression of the
ANG-GH fusion gene, pOGH (ANG N-1498/118) containing the
59-flanking region of the rat ANG gene fused with the human
growth hormone gene as reporter, in OK cells [26]. One likely
explanation for this discrepancy may be that the IRPTC behave
differently from natural proximal tubular cells. Another possibility
is that the IRPTC express a low level of b-adrenoceptors. Indeed,
we often observed a slight increase in the expression of the ANG
in IRPTC at 10211 to 1027 M isoproterenol (approximately 1.4- to
1.5-fold) compared to controls (Fig. 7). However, the increase was
not statistically significant from the controls. More experiments
are warranted concerning the identification and quantification of
b-adrenoceptors in the IRPTC.
On the other hand, the addition of both dexamethasone and
isoproterenol acted synergistically to stimulate the expression of
the ANG gene in IRPTC (Fig. 8). These studies confirm our
previous studies that dexamethasone and isoproterenol or b1-
adrenoceptor activation act synergistically to enhance the expres-
sion of the ANG gene in OK cells [25].
RU 486 is an antagonist of glucocorticoid and competes with
glucocorticoid for binding to the glucocorticoid receptors [27].
Our present studies showed that incubation of IRPTC with RU
486 blocked the stimulatory effect of dexamethasone as shown in
Figure 9. These studies demonstrate that the effect of dexameth-
asone on ANG expression is mediated via the glucocorticoid
receptor complex. Similarly, the addition of propranolol blocked
the enhancing effect of isoproterenol on the ANG expression in
IRPTC when stimulated by dexamethasone and isoproterenol
(Fig. 10). These studies indicate that the enhancing effect of
isoproterenol on ANG expression is mediated via the b-adreno-
ceptors.
At present, the exact molecular mechanism(s) for the synergis-
tic effect of isoproterenol and dexamethasone on the expression
of the ANG in IRPTC is not known. One possible explanation
may be that the addition of dexamethasone stimulates the expres-
sion of b1-adrenoceptors in IRPTC, since a glucocorticoid respon-
sive element (GRE) has been identified in the 59-flanking region
of the b1-adrenoceptor [28]. We have observed, however, that the
pre-incubation of IRPTC with dexamethasone (10211 to 1025 M)
alone for 24 hours did not display any synergism in the presence
of isoproterenol (unpublished results). These studies suggest that
the synergistic effect of dexamethasone and isoproterenol on the
expression of ANG is probably not mediated via the increased
expression of the b1-adrenoceptor in the IRPTC per se, but may
be mediated via the interaction of the activated glucocorticoid
receptor(s) with some undefined nuclear transcription factor, that
is, cAMP-responsive element binding protein, since the studies of
Imai et al [29] have shown that the activated glucocorticoid
receptor interacted with the cAMP-responsive element binding
protein in vitro. Studies are underway in our laboratory to
elucidate the molecular mechanism(s) of the synergistic effect of
isoproterenol and dexamethasone on the expression of the ANG
gene in the kidney proximal tubular cells.
In summary, we have developed a specific radioimmunoassay
(RIA) for recombinant angiotensinogen (rANG). By employing
this RIA, we demonstrated that dexamethasone stimulated the
expression and secretion of ANG by immortalized rat proximal
tubule cells (IRPTC). Isoproterenol alone had no effect. How-
ever, a combination of both dexamethasone and isoproterenol
acted synergistically to stimulate the expression and secretion of
the rANG by IRPTC. The addition of RU 486 or propranolol
inhibited the synergistic effect of dexamethasone and isoprotere-
nol in IRPTC. These results suggest that the high levels of
dexamethasone may act synergistically with b1-adrenoceptor ac-
tivation in the proximal tubular cells to enhance the expression of
the renal ANG. The local formation of renal Ang II might then
modulate the physiology of the renal proximal tubular cells,
including sodium and fluid reabsorption [1–3]. Hence, the local
intrarenal renin-angiotensin system may play an important role in
the development of hypertension.
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APPENDIX
ANG, angiotensinogen; Ang II, angiotensin II; AT1-receptor, angioten-
sin II receptor; CAT, chloramphenicol acetyl transferase; dFBS, depleted
fetal bovine serum; DMEM, Dulbecco’s modified Eagle medium; FBS,
fetal bovine serum; hANG, human angiotensinogen; HRP, horseradish
peroxidase; IgG, rabbit polyclonal antibodies; IPTG, isopropylthiogalac-
toside; IRPTC, immortalized rat proximal tubule cells; IR-rANG, immu-
noreactive rat angiotensinogen; MBP, Maltose-binding protein; MBP-
rANG, Maltose-binding protein fused with rat angiotensinogen; OK,
opossum kidney; oPL, ovine placental lactogen; PAGE-SDS, polyacryl-
amide gel electrophoresis containing sodium dodecyl sulfate; pOCat,
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angiotensinogen-chloramphenicol acetyl transferase fusion gene; pOGH,
angiotensin-growth hormone fusion gene; rANG, rat angiotensinogen;
rGH, rat growth hormone; RIA, radioimmunoassay; RIA-rANG, radio-
immunoassay of rat angiotensinogen; rLH, rat leutinizing hormone; rPRL,
rat prolactin; rTSH, rat thyroid stimulatory hormone.
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